Codex @codex  0

An active site is the region of an enzyme where a substrate binds and undergoes a chemical reaction. In a protein enzyme, it includes the amino acid residues that contact the substrate and those that directly assist catalysis. These roles can overlap: an amino acid side chain can both orient a substrate and participate in chemistry. The active site occupies only part of the folded protein; the remaining amino acid residues help establish its protein structure, stability and movement. An active site need not be a consecutive stretch of protein primary structure: protein folding can bring distant amino acid residues together. A ribozyme instead supplies an RNA active site. See Alberts et al., Molecular Biology of the Cell, Protein Function: binding sites and catalytic sites.

Binding and catalysis answer different questions. A protein binding site recognizes shape and chemistry through such interactions as hydrogen bonds, electrostatics and the hydrophobic effect. At an active site, appropriate positioning also helps a substrate reach the transition state of a chemical reaction. Some amino acid side chains transfer a proton; others participate transiently in a covalent bond. The enzyme-substrate complex is the associated enzyme and substrate, before conversion to a reaction product. Merely accumulating this complex does not establish rapid catalysis: stabilizing the bound substrate without sufficiently stabilizing the transition state can leave a large barrier. The important complementarity is chemical as well as geometric. See Geoffrey M. Cooper, The Cell, The Central Role of Enzymes as Biological Catalysts: substrate binding and transition-state stabilization.

The cartoon makes a useful experimental distinction. Changing a contacting amino acid residue might weaken substrate binding, change the reaction rate, or do both. Changing a distant amino acid residue can also disrupt the active site by changing protein folding. Therefore a loss of activity after a mutation alone does not locate a catalytic group: compare binding, protein structure and enzyme kinetics as well. This is an interpretation guide, not a report of a particular mutation experiment.

A concrete example is hexokinase: it transfers the terminal phosphate group of ATP to the $6$-position hydroxyl group of a sugar such as glucose. Specificity need not mean only one acceptable substrate: the hexokinase reaction class includes several possible acceptor sugars. Which are used, and at what reaction rates, depends on the particular enzyme and conditions. See Swiss Institute of Bioinformatics, ENZYME entry EC 2.7.1.1: hexokinase reaction and acceptor range.

Bennett and Steitz compared yeast hexokinase A crystallized with glucose against hexokinase B crystallized without glucose. X-rays scattered by the crystals supplied diffraction measurements from which the authors reconstructed protein structure; comparing coordinates located movement, rather than measuring a reaction rate. The glucose-containing cleft was narrower: one lobe was rotated by about $12^{\circ }$ relative to the other, with some protein backbone displacements reaching $8\mathring{\mathrm{A}}$. This makes the active site a moving arrangement of interacting groups, rather than a permanent hole. See William S. Bennett Jr. and Thomas A. Steitz, Glucose-induced conformational change in yeast hexokinase, PNAS 75 (1978), 4848–4852.

The structural comparison has two explicit limitations: different forms of hexokinase and different crystal environments were compared, and static coordinates do not record the order of binding and movement. Closure is consistent with induced fit, but those structures alone cannot exclude conformational selection. The solution experiment under induced fit addresses whether compaction also occurs outside a crystal.

A beta sheet consists of extended stretches of protein backbone lying alongside one another, joined by backbone hydrogen bonds. The stretches can belong to different portions of the same polypeptide chain or to different chains.

Each extended stretch is a beta strand. Neighboring beta strands pack side by side, with repeated backbone hydrogen bonds between their backbone $\mathrm{C}=\mathrm{O}$ and $\mathrm{N}-\mathrm{H}$ groups: the oxygen is a hydrogen bond acceptor, and the backbone nitrogen with its attached hydrogen provides a hydrogen bond donor. These are interactions of the shared protein backbone, not merely contacts between amino acid side chains. Unlike an alpha helix, a beta sheet joins adjacent extended stretches rather than coiling one stretch around an axis. See Clark, Douglas and Choi, Biology 2e, 3.4: backbone groups in secondary structure.

Read each beta strand in the sequence direction from the N-terminus toward the C-terminus, even when it is an internal part of a longer polypeptide chain. In a parallel beta sheet, neighboring beta strands run in the same N→C direction; in an antiparallel beta sheet, they run in opposite N→C directions. A three-strand example can therefore have arrows right–right–right or right–left–right. A beta sheet can also mix the two arrangements. Direction does not identify chain membership: a single polypeptide chain can fold back to supply several beta strands, and different polypeptide chains can contribute to one beta sheet. See Alberts et al., Molecular Biology of the Cell: beta-sheet strand arrangements.

The pleated appearance comes from the geometry of the protein backbone. Successive amino acid residues carry amino acid side chains on alternating faces of an ideal beta strand, conventionally drawn above and below the sheet. The attachment positions are the amino acid alpha carbons. Thus a six-position cartoon has groups 1, 3 and 5 on one face and 2, 4 and 6 on the other. This alternation is a spatial pattern, not a rule that alternating positions must contain identical amino acids. See Clark, Douglas and Choi: side chains above and below the pleats.

Real beta sheets commonly twist and curve; pleating does not make them perfectly flat plates. Which beta strands are neighbors, how connecting regions join them, and how their faces pack are features of the three-dimensional protein structure. An alternating pattern in the protein primary structure alone neither establishes a beta sheet nor specifies a unique fold independently of surroundings and interacting molecules. See Breda et al., Protein Structure, Modelling and Applications: extended strands, sheet twist and three-dimensional organization and protein folding.

Why this arrangement is useful: repeated backbone hydrogen bonds organize extended chain regions into a framework that can contribute to the interior of a folded protein. Amino acid side chains and connecting loops give that framework chemical variety and can shape a protein binding site for a ligand. Its attractive feature is the combination of a reusable backbone pattern with variable exposed groups: similar beta sheets can support different recognition surfaces. See Alberts et al.: beta-sheet cores and loops that form binding sites.

Historically, Linus Pauling and Robert B. Corey published The Pleated Sheet, a New Layer Configuration of Polypeptide Chains in PNAS 37, 251–256 (1951). They reasoned from peptide bond geometry and possible backbone hydrogen bonds, proposing an idealized layer rather than measuring every modern beta sheet. Their initial model should not be identified with all present-day beta sheet geometries; they published further pleated-sheet configurations later in 1951. See Pauling and Corey: original 1951 paper and scan, ^[ref], and Pauling and Corey, Configurations of Polypeptide Chains With Favored Orientations Around Single Bonds: Two New Pleated Sheets, PNAS 37, 729–740 (1951).

A disulfide bond is the single covalent bond between the two adjacent sulfur chemical atoms in a disulfide, conventionally written $\mathrm{R}-\mathrm{S}-\mathrm{S}-{\mathrm{R}}^{\prime }$. Here $R$ and $R^{\prime }$ stand for the attached organic groups; they may belong to the same molecule or to initially separate molecules. A disulfide bond is a chemical bridge, rather than a hydrogen bond or a mere contact between nearby groups. Two thiols, $\mathrm{R}-\mathrm{SH}$ and ${\mathrm{R}}^{\prime }-\mathrm{SH}$, can supply its two sulfur endpoints. ^[ref]

The stoichiometry of forming a disulfide bond is especially revealing. Written as an oxidation half-reaction, it isThe reverse reduction half-reaction consumes two Electrons and two hydrogen ions to restore two thiols. Both sides contain two sulfur chemical atoms; the two hydrogen chemical atoms have moved into the two hydrogen ions, and the net electric charge remains zero because $+2-2=0$. Thus one disulfide bond corresponds to two thiol groups and two transferred Electrons. These half-reactions describe redox bookkeeping, not a complete standalone chemical reaction: an accompanying reactant must accept or supply the Electrons, and pH affects the actual protonation of the groups. Mercaptoethanol can promote reduction through exchange of disulfide bonds, but adequate excess and appropriate conditions are needed; adding it does not by itself prove complete reduction. ^[ref]

In a protein disulfide bond, the endpoints are normally the amino acid side chains of two cysteine amino acid residues. An intrachain protein disulfide bond closes an intramolecular bridge within one polypeptide chain; an interchain protein disulfide bond connects different polypeptide chains, and can arise by intermolecular crosslinking of initially separate molecules. Forming or reducing these bridges changes covalent bond connectivity and can change protein structure, while preserving the order of amino acid residues and the peptide bonds in the protein backbone. A complete chemical account of protein primary structure includes crosslinks as well as sequence, so preservation of sequence does not imply preservation of every covalent bond. Mature insulin has two interchain protein disulfide bonds and one intrachain protein disulfide bond. ^[ref]

A bridge is useful because it constrains which parts of a polypeptide chain can move apart without breaking a covalent bond. Its placement therefore matters as well as its presence. The ribonuclease A refolding experiment provides the existing experimental example: breaking and reforming four protein disulfide bonds can accompany loss and recovery of function. Counting four bridges alone cannot tell whether their endpoints have the native pairing. This is an attractive connection between simple chemical counting and the richer problem of protein folding.

How can an experiment reveal an initially hidden disulfide bond? Ellman's reagent, also called DTNB, measures free thiols by producing a yellow absorbing species. Its reactive disulfide bond undergoes exchange with the conjugate base $\mathrm{R}-{\mathrm{S}}^{-}$ of a thiol, producing a mixed disulfide attached to $R$ and one released 2-nitro-5-thiobenzoate species, abbreviated TNB. At the assay pH, the strongly colored form is the dianion $\mathrm{TN}{\mathrm{B}}^{2-}$: one negative charge is on sulfur and the other is on the carboxylic acid-derived $\mathrm{CO}{\mathrm{O}}^{-}$ group. With excess DTNB and complete reaction, one released TNB reports one reacted thiol. George L. Ellman's 1959 paper introduced the tissue assay; it was subsequently reexamined quantitatively. ^{[ref] [ref]}

The modern apparatus can be simple: tubes, pipettes, a buffer solution, cysteine standards, DTNB, and an instrument that measures absorbance through a cuvette at wavelength $412\mathrm{nm}$. The Pierce protocol uses $50\mu \mathrm{L}$ of a $4\mathrm{mg}\mathrm{m}{\mathrm{L}}^{-1}$ DTNB stock, $2.50\mathrm{mL}$ of buffer solution, and $250\mu \mathrm{L}$ of sample. Its buffer solution is $0.1\mathrm{mol}{\mathrm{L}}^{-1}$ sodium phosphate at pH 8.0 with a metal-binding additive. After 15 minutes at room temperature, measure absorbance against a buffer solution plus DTNB blank; run known cysteine concentrations in parallel. The observable is increased yellow color and increased blank-corrected absorbance as more accessible thiols react, rather than direct imaging of disulfide bonds. These are published protocol conditions, not measurements performed for this article. ^[ref]

For a before/after test, split a purified protein sample into matched aliquots. Measure accessible free thiols in one aliquot; subject the other to complete reduction of its disulfide bonds, remove the reducing reagent, then measure the resulting thiols with fresh DTNB. Process the unreduced aliquot through a matching cleanup. Normalize to recovered protein and known dilution, since cleanup can change both. To estimate all reducible protein disulfide bonds, expose buried groups using matching protein denaturation conditions in both aliquots and calibrate in that same chemical solution; a native-accessibility measurement answers a different question. A larger corrected reading after reduction supports conversion of previously unreactive groups into detectable thiols. Attribution to disulfide bonds requires excluding other reducible sulfur modifications. This is a proposed comparison based on the detection principles, not a reconstruction of Ellman's original tissue measurements. ^[ref]

Under the Beer-Lambert law, the blank-corrected absorbance is $A=\epsilon lc$, where $l$ is the cuvette path length, $c$ is the released TNB concentration, and $\epsilon$ is its molar absorption coefficient. Riddles, Blakeley and Zerner measured ${\epsilon }_{412}=14150\mathrm{L}\mathrm{mo}{\mathrm{l}}^{-1}\mathrm{c}{\mathrm{m}}^{-1}$ in dilute aqueous salt chemical solutions, confirming the value independently using cysteine. It must not be applied indiscriminately to other solvents or protein denaturation mixtures. ^[ref] For aliquots compared on the same final volume and protein concentration basis, the ideal estimate isThe factor of two follows from the reduction stoichiometry; ${\bar{n}}_{\mathrm{S}-\mathrm{S}}$ is the number of disulfide bonds per protein molecule, or an average for a mixed population. If the aliquots have different dilutions or recoveries, convert each reading to a common sample basis before subtracting.

As a hypothetical calculation, choose $c_{\mathrm{protein}}=10\mu \mathrm{mol}{\mathrm{L}}^{-1}$ in each final cuvette, two free thiols and two disulfide bonds per protein molecule, and $l=1\mathrm{cm}$. Before reduction, $c_{\mathrm{SH}}=20\mu \mathrm{mol}{\mathrm{L}}^{-1}$ gives $A=0.283$; complete reduction adds four thiols per protein molecule, so $c_{\mathrm{SH}}=60\mu \mathrm{mol}{\mathrm{L}}^{-1}$ gives $A=0.849$. The difference $0.566$ gives $c_{\mathrm{S}-\mathrm{S}}=20\mu \mathrm{mol}{\mathrm{L}}^{-1}$ and ${\bar{n}}_{\mathrm{S}-\mathrm{S}}=2$. The published tube volumes imply a dilution factor $2.80/0.250=11.2$; reversing that dilution multiplies both thiol and protein concentrations by 11.2 and leaves the bridge count per protein molecule unchanged.

Controls determine whether that arithmetic has chemical meaning. Use fresh cysteine standards and a processed blank without protein to detect color generated by residual reducing reagent. Even a reducing reagent containing no thiols can interfere: Han and Han showed that tris(2-carboxyethyl)phosphine, abbreviated TCEP, reduces DTNB to two TNB equivalents per TCEP. ^[ref] In the hypothetical model, $5\mu \mathrm{mol}{\mathrm{L}}^{-1}$ residual TCEP in only the reduced cuvette would add $A=0.1415$ and falsely add $0.5$ bridge per protein molecule. A stable endpoint and agreement after a further reduction treatment help check completion. A sample without DTNB checks its own color; cloudy samples can also attenuate light without producing TNB. Match pH, temperature, accessibility and calibration chemical solution, and minimize delay that permits reoxidation. If two already-free but buried thiols become accessible only in the reduced aliquot, they mimic one new disulfide bond per protein molecule. Finally, bulk absorbance supplies a count under these assumptions: it does not locate the cysteine endpoints, distinguish intrachain from interchain bridges, or establish the native pairing of a protein disulfide bond.

In induced fit, a substrate binds to an enzyme and the resulting enzyme-substrate complex subsequently changes its protein structure. This adjustment can position interacting groups at the active site for catalysis. The mechanistic claim concerns order: binding precedes the relevant change. In conformational selection, the unbound enzyme already visits an alternative protein structure, which the substrate preferentially binds. Both processes can occur in one system. Let $E$ and $E^{\ast }$ denote two structures of the same enzyme, and $S$ a substrate. The limiting routes areThe star labels a structure, not a different protein primary structure, and does not by itself mean catalytic activity. Each reversible arrow abbreviates a step, not the whole catalytic cycle. See Gordon G. Hammes, Yu-Chu Chang and Terrence G. Oas, Conformational selection or induced fit: a flux description of reaction mechanism, PNAS 106 (2009), 13737–13741.

A rigid lock-and-key cartoon usefully suggests selective substrate recognition, but it suppresses movement of the protein and chemical changes at the active site. Replacing it with two static drawings, “open” and “closed”, still does not establish induced fit: both routes above can end at $E^{\ast }S$. Also, if complete closure prevents a substrate entering, the pre-existing structure selected in conformational selection might be partly open and undergo further induced fit after binding. The usefulness of the distinction is that it turns an attractive shape story into questions about enzyme kinetics. Relative traffic through the routes depends on populations, rate constants and free substrate concentration, rather than affinity alone. See Hammes, Chang and Oas, 2009: coupled pathways, their concentrations and the limitations of endpoint structures.

For this analytical illustration, hold the free substrate concentration $s$ constant and assume independent waiting times with exponential distributions of constant rates. The law of mass action gives the binding rate $a=k_{\mathrm{on}}s$; the competing change has rate $b$. The probability density function for binding to happen first at time $t$ is $a{e}^{-(a+b)t}$, because neither event has happened earlier. Its integral isWith the stated invented rate constants, $s=0.1,1,10\mu \mathrm{M}$ gives $1/11,1/2,10/11$, respectively. Raising free substrate concentration makes binding more likely to win this initial competition. This probability is deliberately narrower than a full-route fraction: returns to $E$, later changes and the binding properties of $E^{\ast }$ would all matter for the latter. The illustration explains why timing and concentration must accompany structural evidence, without assigning a binding mechanism to a real enzyme.

A motivating experiment tested the crystal interpretation in solution. McDonald, Steitz and Engelman prepared solutions of monomeric yeast hexokinase B and compared the unbound preparation with sugar-bound preparations. Their apparatus measured small-angle scattering of X-rays; the spatial extent inferred from that readout was the radius of gyration, rather than a catalytic reaction rate. Binding glucose reduced the radius of gyration by $0.95\pm 0.24\mathring{\mathrm{A}}$; binding the phosphorylated glucose product reduced it by $1.25\pm 0.28\mathring{\mathrm{A}}$, as reported by the authors. The glucose change agreed with the reduction calculated from the crystal coordinates. See Robert C. McDonald, Thomas A. Steitz and Donald M. Engelman, Yeast hexokinase in solution exhibits a large conformational change upon binding glucose or glucose 6-phosphate, Biochemistry 18 (1979), 338–342: primary abstract.

The comparison without added substrate supplies a baseline within the same form of hexokinase; the second bound preparation tests another binding condition. Together with the crystal comparison, solution compaction supports closure beyond crystal packing. It still gives an average spatial readout, not a movie of individual binding events, and product-associated compaction does not demonstrate ongoing catalysis. Neither experiment alone proves that binding precedes movement. To distinguish induced fit from conformational selection, structural comparisons must be combined with measurements sensitive to timing and with a model of the relevant populations and enzyme kinetics.

Lysozyme is a protein enzyme that attacks the peptidoglycan of bacterial cell walls. Its active site is a cleft in the folded protein structure, where a suitable substrate can interact with positioned chemical groups. This illustrates why possessing the right amino acid residues is insufficient if their spatial arrangement is lost. See Alberts et al.: lysozyme as a worked example of protein binding and enzyme function.

A concrete structural example is Cheetham, Artymiuk and Phillips's 1992 study of hen egg-white lysozyme bound to a short carbohydrate that inhibits its action. The bound carbohydrate occupies part of the active site; it is not a reacting substrate in this complex. The study describes specific interactions and changes of shape accompanying binding. Thus a real binding site has chemical interactions and flexibility as well as a geometric outline. See Cheetham, Artymiuk and Phillips, 1992: structure of a lysozyme complex with bound inhibitor and RCSB PDB entry 1HEW: the authors' structure and bound three-unit carbohydrate. The diagrams above illustrate the idea; their twelve-residue strings are not lysozyme sequences or coordinates.

A protein is a biological molecule made of one or more polypeptide chains: ordered amino acid residues joined by peptide bonds. Biological translation assembles a chain in the order specified by messenger RNA codons. Protein folding then brings parts of that chain into spatial relationships that support its function. See Cooper, The Cell: protein composition and structure. These processes can overlap in a biological cell; the sequence-to-shape explanation does not require waiting until biological translation finishes before any folding begins. See Cooper, The Cell: protein folding and processing.

The useful connection is from information to physical work. A protein's protein primary structure records an order; its protein tertiary structure can bring distant amino acid residues together at an active site. An enzyme uses such an arrangement to recognize a substrate and accelerate a chemical reaction. Other proteins serve as receptors, membrane transport proteins or structural material. For example, actin assembles into filaments whose mechanical properties can be described by biopolymer mechanics. See Alberts et al., Molecular Biology of the Cell: protein function and binding.

Order matters beyond composition. Let A stand for alanine and M for methionine, and read from the N-terminus to the C-terminus. The illustrative strings AMAMAMAMAMAM and AAAAAAMMMMMM each contain exactly six A and six M amino acid residues. Each has $12-1=11$ peptide bonds when made into one unbranched polypeptide chain. In the first string all eleven neighboring pairs have different letters; in the second only the pair at positions 6 and 7 does. A composition histogram therefore loses information about which amino acid residues are neighbors. Their arrangements can affect protein folding and function; these short invented strings neither specify a known functional protein nor establish what shape either would adopt.

Protein structure is a moving arrangement, not a permanently rigid outline. Substrate binding can change an enzyme's shape through induced fit, and a functional protein can include flexible regions. Sequence, surroundings and interacting molecules must therefore be considered together. See Alberts et al.: binding, conformational changes and protein function.

A protein binding site is a region of a protein structure that interacts with a ligand. Its arrangement of amino acid residues helps determine recognition; connecting loops supported by a beta sheet can contribute to it. An enzyme's active site binds a substrate and accelerates a chemical reaction. See Alberts et al.: protein binding sites and active sites.

Protein structure describes both the chain's chemical organization and its spatial arrangement. Four levels answer different questions: protein primary structure gives the order; protein secondary structure gives recurring local patterns; protein tertiary structure gives one chain's overall arrangement; protein quaternary structure gives the assembly of multiple chains. These are levels of description, not four mandatory stages that every protein must pass through. See Clark, Douglas and Choi: four levels of protein structure.

A biochemical receptor is a protein that recognizes a signal and couples its detection to a biological effect. Its binding partner is a ligand; recognition depends on compatible shape and chemical interactions at a binding site within the protein structure. Specificity is selective recognition, not a guarantee that only one ligand can bind. Binding also need not activate the receptor: a competing ligand may occupy it while preventing activation by another ligand. See Alberts et al., Molecular Biology of the Cell, 4th edition: protein binding and specificity.

Compare a cell-surface receptor, accessible to an extracellular ligand, with an intracellular receptor, whose ligand must reach the interior. A cell-surface receptor can detect a hydrophilic ligand without transporting it through the cell membrane. In contrast, some membrane-permeable signals reach intracellular receptors that regulate gene expression. Location and downstream coupling are separate distinctions: an ionotropic receptor directly gates an ion channel, whereas a metabotropic receptor works through intracellular signal transduction. See Clark, Douglas and Choi, Biology 2e, 9.1: receptor locations and mechanisms.

Receptor binding occupancy quantifies recognition separately from response. A dissociation constant measures binding in a specified equilibrium model; it does not by itself predict the cellular effect. This separation is useful when comparing signals that bind equally well but produce different responses, or when interpreting a binding experiment alongside a functional measurement.

Anfinsen, Haber, Sela and White's 1961 experiments began by treating bovine pancreatic ribonuclease A with mercaptoethanol in $8\mathrm{mol}{\mathrm{L}}^{-1}$ urea. Urea promotes unfolding; mercaptoethanol breaks protein disulfide bonds. The peptide bonds along the chain remain intact. After separating the chain from those reagents, the authors allowed its reactive sulfur groups to form protein disulfide bonds in the presence of molecular oxygen, at pH $8.2$ and temperature $23$–$24{}^{\circ }\mathrm{C}$. They examined protein concentrations of $0.1$ and $2.0\mathrm{mg}\mathrm{m}{\mathrm{L}}^{-1}$. Measurements showed recovery of native properties under these conditions; the isolated major component had normal activity toward both RNA and a synthetic substrate. See Anfinsen, Haber, Sela and White, The Kinetics of Formation of Native Ribonuclease during Oxidation of the Reduced Polypeptide Chain, PNAS 47, 1309–1314 (1961), pp. 1309–1311.

The observation supports the sufficiency of that intact sequence to recover native protein structure in the tested surroundings without a folded template. It does not establish that every protein refolds, that the original living biological cell needed no assistance, or that activity always returns immediately. Protein folding, forming protein disulfide bonds and recovering an active site are related processes rather than interchangeable measurements.

Anfinsen's lecture also discusses forming protein disulfide bonds while the chain remains in concentrated urea. This gave mostly inactive material; after removing urea, a small amount of mercaptoethanol permitted rearrangement toward the native form. As an exact combinatorial check, eight labeled reactive sulfur groups have $7\times 5\times 3\times 1=105$ ways to be paired into four protein disulfide bonds: choose the partner of one group, then repeat with the unpaired groups. Only one pairing is the native one. Equal counting does not mean that all pairings are equally likely experimentally, nor that actual protein folding searches them uniformly. See Anfinsen's Nobel lecture, 1973 publication: scrambled ribonuclease and the 105 pairings, p. 223.